AstraZeneca Thailand Wins Two ACES Awards 2022: “Industry Champions of the Year” and “Community Initiative”
BANGKOK, Nov. 25, 2022 /PRNewswire/ -- AstraZeneca (Thailand) Co., Ltd., was recently honoured with two accolades in the categories of Industry Champions of the Year and Community Initiative at the Asia Corporate Excellence & Sustainability Awards 2022 (ACES Awards 2022). Pucharapan Holim, Corporate Affairs Manager, AstraZeneca Thailand, receiving the Industry Champions of the Year and...
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation
AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients worldwide HONG KONG and SHENZHEN, China, Nov. 25, 2022 /PRNewswire/ -- XtalPi announced today that they are embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison...
Hugel’s ‘Letybo’ First in Korea to Obtain Marketing Approval from Australia
- Obtained marketing approval on the 23rd (local time) from the Therapeutic Goods Administration (TGA) of Australia for the indication of glabellar lines - First shipment and local launch planned for Q1 2023...Plans to cooperate with major chain clinics and key opinion leaders SEOUL, South Korea, Nov. 24, 2022 /PRNewswire/ -- Hugel,...
AstraZeneca Certified Best Place to Work in Indonesia for 2022
JAKARTA, Indonesia, Nov. 24, 2022 /PRNewswire/ -- AstraZeneca Indonesia, affiliate of the multinational pharmaceutical and biopharmaceutical company, was recently recognized as the Best Place to Work in Indonesia for 2022. The company received outstanding scores across several aspects of their workplace such as advancement opportunities, career training, high-level mentoring learning opportunities, environmental and social initiatives, competitive benefits and giving...
Mabwell Announces the U.S. FDA approval of 9MW3011 (FIC) for IND
SHANGHAI, Nov. 24, 2022 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that its clinical trial application for 9MW3011 Injection used in patients with polycythemia vera was formally approved by the United States Food and Drug Administration (FDA). 9MW3011 is monoclonal antibody with an innovative target. It is independently developed by...
Rokid and Eyedaptic Launch EYE5 to Help AMD Patients Enhance Their Vision
HANGZHOU, China, Nov. 24, 2022 /PRNewswire/ -- Recently, Rokid, an augmented reality glasses manufacturer, partnered with Eyedaptic to unveil the all-new EYE5 smart glasses at the American Academy of Optometry 2022 Annual Meeting and Expo. The latest model brings wearability to a whole new level and covers the widest range of use cases for central vision loss including Diabetic Retinopathy...
Vieworks exhibits at RSNA 2022 with its complete lineup of next generation x-ray flat panel detectors
ANYANG, South Korea, Nov. 24, 2022 /PRNewswire/ -- Vieworks, a leading digital x-ray imaging solution provider based in South Korea, will be exhibiting its complete lineup of DR flat panel detectors (FPD) and dynamic FPDs at RSNA 2022 (South Hall #1723) from November 27th to November 30th. Celebrating the FDA-approval of VIVIX-S F series, the...
Edenlux launches AI-based service “Otus Plus Eye Health Care Report”
SEOUL, South Korea, Nov. 24, 2022 /PRNewswire/ -- On November 24, Edenlux (CEO Sy Park) announced that it will provide an artificial intelligence (AI) eye health management report for the users of Otus Plus, its flagship product. Edenlux Otus Plus APP The company, which is a member of the Born2Global Centre (CEO Kim Jong-gap), created the Otus...
IonOpticks ushers in a new age of proteomics with Aurora Frontier
MELBOURNE, Australia, Nov. 24, 2022 /PRNewswire/ -- The field of proteomics is set to be revolutionised with the launch today of IonOpticks' Aurora Frontier that achieves more than 10,000 proteins per sample. This near-full proteome coverage, a depth previously considered unattainable, unlocks the potential for ground-breaking scientific discoveries in human health. Proteomics provides a greater understanding of the complexity of...
The 13th China (Taizhou) International Medical Expo successfully held
TAIZHOU, China, Nov. 24, 2022 /PRNewswire/ -- From November 19 to 21, the 13th China (Taizhou) International Medical Expo was held in China Medical City (CMS). Themed "Healthy China Strategy Leading the Construction of Demonstration Zones", this year's expo held 23 special events including the CMS Policy Releasing and Project Signing Ceremony, and the 9th China (Taizhou) International Big...
